Trusted by the world’s leading institutions

clients clients clients clients clients clients clients clients clients clients clients
Release date: 4-Jun-2024 2:05 PM EDT
An anti-inflammatory curbs spread of fungi causing serious blood infections
UC Davis Health

Study finds that mesalamine, a common anti-inflammatory drug, can fight the fungus Candida albicans in the gut, potentially preventing the risk of invasive candidiasis in patients with blood cancers.

Release date: 4-Jun-2024 1:30 PM EDT
Programs to Prevent Sexual Violence Show No Evidence of Curbing Assaults
Association for Psychological Science

Sexual violence prevention programs effectively change ideas and beliefs that underscore assaults, but show no evidence of reducing their actual occurrence, a new analysis shows.

Newswise: UC San Diego Health First in Region to Provide Novel Therapy for Melanoma
Release date: 4-Jun-2024 1:05 PM EDT
UC San Diego Health First in Region to Provide Novel Therapy for Melanoma
UC San Diego Health

Breakthrough one-time cancer treatment option for select patients with metastatic melanoma and solid tumors now offered at UC San Diego Health.

Release date: 4-Jun-2024 12:05 PM EDT
Researchers debut novel manifold design theory
University Of Illinois Grainger College Of Engineering

University of Illinois researcher Kyle Smith, along with doctoral students Md Habibur Rahman and Vu Do, master’s student Colby Warden, and recent graduate Irwin Loud IV (MSME 2023), have published their new manifold design theory (patent pending) in Physics of Fluids. Their paper, “A Compact, Low-Pressure Manifold with Uniform Flow at Low Reynolds Number,” was also selected by the journal’s editors as a featured article.

Newswise: Molecular switch linked to lineage plasticity, therapy resistance
Release date: 4-Jun-2024 12:05 PM EDT
Molecular switch linked to lineage plasticity, therapy resistance
UT Southwestern Medical Center

Two genes working in tandem play a critical role in shaping the identity and behavior of prostate cancer cells and their response to treatment, UT Southwestern Medical Center researchers report. The findings, published in Cancer Discovery, offer crucial insights into how cancer cells evade the current standard-of-care treatments and provide a potential target for the development of novel prostate cancer therapies.

Newswise: 1920_deep-brain-stimulation-cedars-sinai.jpg?10000
Release date: 4-Jun-2024 11:05 AM EDT
Can Deep Brain Stimulation Help More Patients?
Cedars-Sinai

Deep brain stimulation procedures use electrical pulses to disrupt tiny portions of the brain and halt epileptic seizures or disease-related tremor. The therapy is invaluable, but the basic technology has not advanced in decades.

Newswise: Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer
Release date: 4-Jun-2024 11:05 AM EDT
Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer
Wistar Institute

Wistar scientists have built upon BTE technology to develop new and improved recombinant and synthetic DNA versions of therapeutic antibodies that target CA9, called Persistent Multivalent T Cell Engager (CA9-PMTE), that shows promise in pre-clinical models as a potent, long-lasting treatment against ccRCC.

Release date: 4-Jun-2024 11:05 AM EDT
Comparative Study on Dual vs Single Cardioversion for Atrial Fibrillation in Obese Patients
Ochsner Health

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial fibrillation and obesity.

Newswise: Mapping Lava Flows with Groundbreaking Field Instrument
30-May-2024 9:05 AM EDT
Mapping Lava Flows with Groundbreaking Field Instrument
American Institute of Physics (AIP)

In Review of Scientific Instruments, researchers from the University at Buffalo develop a tool for measuring the viscosity of lava that could increase our understanding of molten rock as well as better improve models of its movement, giving authorities crucial guidance for keeping people safe.

Newswise: steven_frank.jpg.resize.405.575.high.jpg
3-Jun-2024 8:05 AM EDT
ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial
University of Texas MD Anderson Cancer Center

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy (IMRT) as part of chemoradiation treatment for patients with oropharyngeal (head and neck) cancer.


close
1.75723